GlassScriptPhysician profile
William Gerald Austen
NPI 1649269531
$150,481.56
in general payments reported to CMS, 2019-2025
17 companies · $3,974 in 2025
The $3,974 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $214 · 2021: $625 · 2022: $64K · 2023: $66K · 2024: $16K · 2025: $3,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $22K · Food and Beverage: $5,009 · Travel and Lodging: $3,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,593.36 |
| Consulting Fee | $22,064.58 |
| Food and Beverage | $5,009.24 |
| Travel and Lodging | $3,673.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $127,710.81 | 2019-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Novo Nordisk As | $14,768.71 | 2024 | |
| Tela Bio, INC. | $4,272.13 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $1,318.97 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $475.26 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $425.56 | 2022-2025 | Avance Nerve Graft |
| Innovation Technologies INC | $388.11 | 2022-2023 | Irrisept |
| Kls-Martin L.P. | $213.70 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $160.12 | 2025 | |
| Becton, Dickinson and Company | $158.48 | 2025 | Phasix Mesh |
| Kerecis Limited | $155.95 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $146.30 | 2023-2025 | |
| Organogenesis INC. | $124.98 | 2024 | Puraply Wound Matrix |
| Coopersurgical, INC. | $77.15 | 2025 | Onetrac Lx |
| Checkpoint Surgical, INC | $38.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23.47 | 2023 | |
| Galderma Laboratories, L.P. | $22.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Austen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.